Epstein-Barr risk increased by Immune Molecule Deficiency
upi.com
Researchers from the National Institutes of Health National Institute of Allergy and Infectious Diseases, or NIAID, have found a genetic immune disorder causing increased risk and poor control of Epstein-Barr virus and EBV-associated cancer.